NCT04190667 |
|
Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer
|
View
|
NCT04508803 |
|
Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer
|
View
|
NCT04712890 |
|
Determination of Prevalence and Features of HRRm mCRPC ADAM
|
View
|
NCT06033092 |
|
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
|
View
|
NCT02624973 |
|
PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial
|
View
|
NCT03040791 |
|
Nivolumab in Prostate Cancer With DNA Repair Defects ImmunoProst Trial
|
View
|
NCT02401347 |
|
Phase II Trial of Talazoparib in BRCA12 Wild-type HER2-negative Breast Cancer and Other Solid Tumors
|
View
|
NCT05011383 |
|
High Dose Testosterone for ATM CDK12 or CHEK2 Altered Prostate Cancers
|
View
|
NCT05033756 |
|
Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency COMPRENDO
|
View
|
NCT05097274 |
|
The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation
|
View
|
NCT03012321 |
|
AbirateronePrednisone Olaparib or AbirateronePrednisone Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
|
View
|
NCT06177171 |
|
Olaparib and ASTX727 in BRCA12- and Homologous Recombination Deficient HRD-Mutated Tumors
|
View
|
NCT06392841 |
|
Niraparib Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations
|
View
|
NCT03786796 |
|
Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations
|
View
|
NCT04254133 |
|
Genetic Information to Inform Treatment and Screening for Prostate Cancer GIFTS Study
|
View
|
NCT04265937 |
|
ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies
|
View
|
NCT05787587 |
|
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
|
View
|
NCT02952534 |
|
A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
|
View
|